[1] TAN J.Analysis of the lastest incidence and fatality rate of tumors in China and the rest of the world[R].Chin Cancer Registry Annu Rep,2013.(in Chinese)谭健.中国和全球最新肿瘤发病率和死亡率解析[R].中国肿瘤登记年报,2013.
|
[2]FENG JJ,JIA GZ,TAN GY,et al.Changes of serum level of carbohydrate antigen CA19-9 in patients with liver diseases and its clinical significance[J].The J Pract Med,2008,25(9):1043-1044.(in Chinese)逢金聚,贾桂芝,谭国英,等.肝病患者肿瘤标记物CA199水平变化及其临床意义[J].实用医学杂志,2008,25(9):1043-1044.
|
[3]KIEBACK DG.Adenovirus-mediated thymidine kinase gene therapy induces apoptosis in human epithelial O-varian cancer cells and damages PARP-1[J].In Vivo,2009,23(1):77-80.
|
[4]CHO BB,TOLEDO-PEREYRA LH.Caspase-independent programmed cell death following ischemic stroke[J].J Invest Surg,2008,21(3):141-147.
|
[5]NOSHO K,YAMAMOTO H,MIKAMI M,et al.Overexpression of poly(ADP-ribose)polymerase-1(PARP-1)in the early stage of colorectal carcinogenesis[J].Eur J Cancer,2006,42(14):2374-2381.
|
[6]OSSOVSKAYA V,KOO IC,KALDJIAN EP,et al.Upregulation of poly(ADP-ribose)polymerase-1(PARP-1)in triple-negative breastcancer and other primary human tumor types[J].Genes Cancer,2010,1(8):812-821.
|
[7]LI Y,WEI W,LYU SQ,et al.Effects of PARP-1 on angiogenesis of ovarian cancer[J].J Shandong Univ:Health Sciences,2014,52(4):97-106.(in Chinese)李燕,尉蔚,吕树卿,等.PARP-1对卵巢癌血管生成的影响[J].山东大学学报:医学版,2014,52(4):97-106.
|
[8]NOMURA F,YAGUCHI M,TOGAWA A,et al.Enhancement of polyadenosine diphosphate ribosylation in human hepatocellular carcinoma[J].Gastroenterol Hepatol,2000,15(7):529-535.
|
[9]FREDERICK K,MORITZVON W,ALBRECHT S,et al.High nuclear poly-(ADP-ribose)-polymerase expression is prognostic of improved survival in pancreatic cancer[J].Histopathology,2012,61(6):409-416.
|
[10]XIE QX,LIN XC,HAN CX,et al.Significance of Caspase-3 expression in renal cell cancer[J].China Med Eng,2005,13(5):486-488.(in Chinese)谢庆祥,林吓聪,韩聪祥,等.Caspase-3在肾细胞癌中的表达及其意义[J].中国医学工程,2005,13(5):486-488.
|
[11]WINTER NR,KRAMER A.Loss of Caspase-1 and Caspase-3 protein expression in human prostate cancer[J].Cancer Res,2001,61(10):1277-1232.
|
[12]WANG CY,MENG LX,DING ZJ.Expression of PTEN,Survivin and Caspase-3 in human esophageal squmous carcinoma[J].J Mod Oncol,2015,23(4):493-496.(in Chinese)王传艳,孟令新,丁兆军.PTEN、Survivin和Caspase-3在食管鳞癌中的表达[J].现代肿瘤医学,2015,23(4):493-496.
|
[13]LONG H,WU QM,MA SL,et al.Expression of Midkine and Caspase-3 and their relationship with apoptosis in pancreatic cancer[J].World Chin J Dig,2008,16(35):4015-4019.(in Chinese)龙辉,吴清明,马松林,等.Midkine和Caspase-3在胰腺癌中的表达与细胞凋亡的关系[J].世界华人消化杂志,2008,16(35):4015-4019.
|
[14]DU Y,FENG YZ,LI F.Expression of livin and caspase-3 and their clinical significance in pancreatic carcinoma[J].Chin J Clin Exp Pathol,2009,25(6):610-614.(in Chinese)杜缘,冯一中,李峰.胰腺癌中livin、caspase-3的表达及其临床意义[J].临床与实验病理学杂志,2009,25(6):610-614.
|
[15]KOH DW,DAWSON TM,DAWSON VL.Mediation of cell death by poly(ADP-ribose)polymerase-1[J].Pharmacol Res,2005,52(1):5-14.
|
[16]SUI WY,CHEN CY,LUO ZY,et al.The expression of PAPR-1 and Caspase-3 in human breast cancer and their clinical significance[J].J Univ Sourth China:Med Edit,2010,38(2):210-213.(in Chinese)眭文妍,陈春燕,罗招阳,等.PARP-1和Caspase-3在乳腺癌组织中的表达及临床意义[J].南华大学学报:医学版,2010,38(2):210-213.
|
[17]GAO J,CHEN HL.Caspase-3,PARP proteins expression and their significances in human lung cancer[J].J Mathematical Med,2006,19(1):34-36.(in Chinese)高俊,陈洪雷.Caspase-3、PARP蛋白在肺癌组织中的表达及临床意义[J].数理医药学杂志,2006,19(1):34-36.
|
[18]QI SQ,DE S,LI DM,et al.Expressions of PARP-1,Caspase-3,survivin and Bax in cervical squamous cell carcinoma tissues and their clinical significances[J].J Jilin Univ:Med Edit,2013,39(3):512-516.(in Chinese)齐斯琴,德胜,李冬梅,等.子宫颈鳞癌组织中PARP-1、Caspase-3、survivin和Bax的表达及其临床意义[J].吉林大学学报:医学版,2013,39(3):512-516.
|
[19]HU SM,ZHANG SD,HAO YP,et al.Expressions and significance of PARP-1 and Caspase-3 in colorectal neoplasms[J].Chin J Gastroenterol,2009,14(2):83-87.(in Chinese)胡顺明,张世栋,郝艳萍,等.PARP-1和Caspase-3在结直肠肿瘤中的表达和意义[J].胃肠病学,2009,14(2):83-87.
|
1. | 朱成诚,丁世兰. 超声剪切波弹性成像对肝纤维化的临床应用进展. 现代医药卫生. 2022(22): 3874-3879+3883 . ![]() | |
2. | 肖毅,秦建伟. 肝硬化患者门静脉压力、脾静脉血流参数与SWE结果的特征分析. 甘肃科技. 2020(12): 101-104 . ![]() | |
3. | 董丙田,黄枢. 超声弹性成像在肝脏疾病的临床应用. 医学综述. 2019(05): 1002-1006 . ![]() | |
4. | 刘旭. 门静脉右支前间隙行磁共振改良测量对肝纤维化和肝硬化的诊断效果. 肝脏. 2019(05): 541-544 . ![]() | |
5. | 杨淑丽,诸绍锋,张蕾,石鹏,王姜莹,傅佳. 超声实时组织弹性成像定量分析对肝脏纤维化程度的诊断和鉴别诊断价值. 中国临床保健杂志. 2019(04): 526-529 . ![]() | |
6. | 林培艺. 无创性肝纤维化检测对肝硬化严重程度的评估作用. 慢性病学杂志. 2019(07): 1109-1110+1113 . ![]() | |
7. | 秦敏. 术前瞬时弹性超声检查对肝内结石肝切除术安全性的影响. 肝脏. 2019(08): 935-938 . ![]() | |
8. | 许琴,贡雪灏,郭国强. 实时剪切波弹性成像对慢性乙型肝炎患者早期肝纤维化的诊断价值. 临床和实验医学杂志. 2019(20): 2225-2227 . ![]() | |
9. | 孟艳,隆仙琴,李杰,丁文波. RTE与VTI对肝脏局灶良恶性病变的诊断. 中国临床研究. 2018(02): 255-258 . ![]() | |
10. | 杨皖东,肖春华,陈晓,普慧敏. 弹性成像技术对肝移植供体评估的研究进展. 中国当代医药. 2018(03): 18-20 . ![]() | |
11. | 徐列明. 中医药抗肝纤维化疗效评价的探索. 临床肝胆病杂志. 2017(05): 825-828 . ![]() | |
12. | 梁健,钟碧莹,汤茵,肖秀金,叶红. 肝纤维化检测在非酒精性脂肪肝诊断中的应用研究. 中国卫生标准管理. 2017(17): 110-113 . ![]() |